Target intelligence / Profile preview

CS3 fimbrial subunit (CS3)

Target
CS3
Molecular classification
Bacterial adhesin, Fimbrial protein, Other
01

Overview

The CS3 fimbrial subunit is a critical surface protein found on Enterotoxigenic Escherichia coli (ETEC), one of the leading causes of bacterial diarrhea worldwide (WHO, 2023). It is a component of the Colonization Factor Antigen II (CFA/II) complex and functions as an adhesin, mediating the attachment of the bacteria to the human intestinal mucosa (UniProt: P0CK95). This attachment is a prerequisite for the delivery of enterotoxins that cause fluid secretion and diarrhea (Qadri et al., 2005). Because of its prevalence in clinical ETEC isolates and its essential role in pathogenesis, CS3 is a primary target for the development of vaccines, such as the oral inactivated vaccine ETVAX (Lundgren et al., 2014). Therapeutic strategies focus on neutralizing CS3 to prevent bacterial colonization and reduce the global burden of diarrheal disease (Svennerholm, 2011). Targeting this subunit aims to provide broad protection against a significant proportion of ETEC infections globally.

Other names
CstHCS3 pilinColonization factor antigen II component CS3CFA/II CS3
02

Mechanism of action

Vaccines and antibodies targeting the CS3 fimbrial subunit work by inducing or providing immunity that blocks the attachment of Enterotoxigenic Escherichia coli (ETEC) to the intestinal epithelium, thereby preventing colonization and subsequent toxin-mediated diarrhea (Qadri et al., 2005; UniProt: P0CK95).

03

Biological functions

Bacterial adhesionHost cell colonizationPathogenesisOther
04

Disease associations

InfectionOther
05

Safety considerations

Strain-specific immunityPotential for low immunogenicity in certain populationsGastrointestinal side effects from oral whole-cell vaccines (Lundgren et al., 2014)
06

Interacting drugs

ETVAX

1 more in the full profile.

07

Biomarkers

Anti-CS3 IgA antibody levelsAnti-CS3 IgG antibody levels

Beyond the preview

Go deeper on CS3 fimbrial subunit (CS3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on CS3 fimbrial subunit (CS3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call